← Earnings Calls
CHD FY2026 Q2 Raised

Church & Dwight Company, Inc. earnings call

Jul 31, 2026 · 10:00 ET Lee McChesneyRick Dierker earningscall_biz
Buzzberg read

Raised full-year organic sales and EPS guidance

Church & Dwight reported a strong Q2 2026 with 5.8% organic sales growth, well ahead of guidance, driven by broad-based volume growth across all divisions. Management raised full-year guidance for sales, EPS, and cash flow, and highlighted the successful acquisition of Miss Mouth. Q2 organic sales +5.8% vs 3% guide, on 4.3% volume and 1.5% price/mix.

Buzzberg read Raised full-year organic sales and EPS guidance Church & Dwight reported a strong Q2 2026 with 5.8% organic sales growth, well ahead of guidance, driven by broad-based volume growth across all divisions. Management raised full-year guidance for sales, EPS, and cash flow, and highlighted the successful acquisition of Miss Mouth. Q2 organic sales +5.8% vs 3% guide, on 4.3% volume and 1.5% price/mix. Read full analysisCollapse analysis

Church & Dwight reported a strong Q2 2026 with 5.8% organic sales growth, well ahead of guidance, driven by broad-based volume growth across all divisions. Management raised full-year guidance for sales, EPS, and cash flow, and highlighted the successful acquisition of Miss Mouth. Q2 organic sales +5.8% vs 3% guide, on 4.3% volume and 1.5% price/mix.

  • Gross margin +40 bps despite 400 bps of cost inflation, mitigated by productivity.
  • Raised FY26 organic sales guidance to 4-5% and EPS growth to 6-8%.
  • TheraBreath gained 4.5 share points in mouthwash (25.3% share); toothpaste launch at 1% share.
Revenue$1.53B+4% QoQ
EPS$0.89-6% QoQ
Gross margin45.35%Reported
Operating margin18.07%Reported
6 grounded callouts

What matters now

The highest-signal changes from the call.

01
Guidance

Raised full-year organic sales and EPS guidance

02
Brand Momentum

TheraBreath gains record mouthwash share

03
M&A

Miss Mouth acquisition off to strong start

Show 3 more callouts
04
International

International organic sales growth of 9.1%

05
Costs

Middle East conflict driving $30 million cost headwind

06
Demand

Category growth exceeds expectations, driven by value segment

Reported period

Actuals

MetricReportedChange
Revenue$1.53B+4% QoQ
EPS$0.89-6% QoQ
Gross margin45.35%Reported
Operating margin18.07%Reported
Free cash flow$0.2569BReported
Capex$0.0299BReported
Forward-looking

Forward guidance

MetricPeriodRangeMidpointStatus
EPSFY2026 Q3$0.89$0.89Guided
Free cash flowFY2026$1.175B$1.175BRaised
RevenueFY20264%–5%4.5%Raised
AI, capex & demand read

Management read

Tone

Upbeat

Management expressed strong confidence and optimism, citing broad-based growth, share gains, and raised guidance, with phrases like 'I'm more optimistic about the future than I've ever been.'

AI

Management AI read

Management mentioned spending money behind AI initiatives, pulling some forward to scale faster, leveraging AI among other tools to compete on affordability and drive speed and agility.

Capex

Investment and capacity

Capital expenditures for the first half were $61.8 million, with full-year capex expected at approximately $130 million or roughly 2% of sales. The ERP system is noted as an enabler for fast acquisition integration.

all 2 named companies below

Companiesreturns since call

Competitors

Competitors

Henkel significantly increased promotional spending on laundry detergent, which CHD chose not to match, but CHD maintained its share despite this aggressive push.

Evidence
“Hankel was up 1100 basis points and Proctor was up almost 200 basis points as well.”
Rick Dierker
External signals

Supply-chain alpha · 1returns since call

A1

CHD gained 4.5 market share points in mouthwash and held share in laundry despite major competitors increasing promotion by 1100 bps and 200 bps respectively.

Evidence
“Hankel was up 1100 basis points and Proctor was up almost 200 basis points as well. And so despite that, the value segment grew and we maintained our share.”
Methodology & coverage

Management-only analysis. All 2 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.